These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9010317)

  • 1. Multiple splicing variants of the estrogen receptor are present in individual human breast tumors.
    Zhang QX; Hilsenbeck SG; Fuqua SA; Borg A
    J Steroid Biochem Mol Biol; 1996 Nov; 59(3-4):251-60. PubMed ID: 9010317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
    Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
    Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
    Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.
    Horvath G; Leser G; Helou K; Henriksson M
    Gynecol Oncol; 2002 Feb; 84(2):271-9. PubMed ID: 11812086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues.
    Poola I; Speirs V
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):459-69. PubMed ID: 11738556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
    Fuqua SA; Fitzgerald SD; Chamness GC; Tandon AK; McDonnell DP; Nawaz Z; O'Malley BW; McGuire WL
    Cancer Res; 1991 Jan; 51(1):105-9. PubMed ID: 1988075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
    Rice LW; Jazaeri AA; Shupnik MA
    Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. Gallen endocrine response classes predict recurrence rates over time.
    Koornstra RH; Beelen KJ; Vincent AD; van der Noort V; van Diest PJ; Linn SC
    Breast; 2015 Dec; 24(6):705-12. PubMed ID: 26429398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
    Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR
    Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of estrogen-receptor exon-5-deletion variant in relapse tissues of human breast cancer.
    Gallacchi P; Schoumacher F; Eppenberger-Castori S; Von Landenberg EM; Kueng W; Eppenberger U; Mueller H
    Int J Cancer; 1998 Feb; 79(1):44-8. PubMed ID: 9495357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
    Chan CM; Dowsett M
    J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of alternatively spliced estrogen and progesterone receptor transcripts in human breast cancer.
    Balleine RL; Hunt SM; Clarke CL
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1370-7. PubMed ID: 10199781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.
    Johnston SR; Saccani-Jotti G; Smith IE; Salter J; Newby J; Coppen M; Ebbs SR; Dowsett M
    Cancer Res; 1995 Aug; 55(15):3331-8. PubMed ID: 7614468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor variants in normal human mammary tissue.
    Leygue ER; Watson PH; Murphy LC
    J Natl Cancer Inst; 1996 Mar; 88(5):284-90. PubMed ID: 8614007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells.
    Miksicek RJ; Lei Y; Wang Y
    Breast Cancer Res Treat; 1993; 26(2):163-74. PubMed ID: 8219253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; Martino S; Osborne CK
    Int J Cancer; 2000 Mar; 89(2):111-7. PubMed ID: 10754487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer.
    Leygue E; Huang A; Murphy LC; Watson PH
    Cancer Res; 1996 Oct; 56(19):4324-7. PubMed ID: 8813116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.